Depression in older adults with epilepsy: Pathophysiology and management considerations
- PMID: 40897131
- PMCID: PMC12414575
- DOI: 10.1016/j.yebeh.2025.110692
Depression in older adults with epilepsy: Pathophysiology and management considerations
Abstract
Older adults with epilepsy are at an increased risk for comorbid depression, which worsens their quality of life. This review aims to outline the pathophysiological mechanisms thought to underly the comorbidity of depression in older adults with epilepsy and propose clinical and pharmacological considerations for the holistic management of depression in this population. Indeed, there is a wide range of reported prevalence of depression in older adults with epilepsy, yet these are likely underestimates since depression is underdiagnosed in this population. Age-related drivers of depression include biological and social risk factors such as neurodegenerative changes, inflammation, cerebrovascular dysfunction, social isolation, stigma, and poor health status. Additional contributors related to epilepsy include the impact of seizures, the effects of anti-seizure medications, and the role of sleep-disordered breathing. Therefore, the management of depression in older adults with epilepsy is centered on screening for depression and obstructive sleep apnea, careful choice of anti-seizure medications and anti-depressants, and the provision of social and psychological support.
Keywords: Aging; Anti-seizure medications; Depression; Epilepsy; Older adults; Seizures.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Rani sarkis reports financial support was provided by National Institute of Neurological Disorders and Stroke. RANI SARKIS reports a relationship with National Institute of Neurological Disorders and Stroke that includes: funding grants. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Antidepressants for people with epilepsy and depression.Cochrane Database Syst Rev. 2014 Dec 3;2014(12):CD010682. doi: 10.1002/14651858.CD010682.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2021 Apr 16;4:CD010682. doi: 10.1002/14651858.CD010682.pub3. PMID: 25464360 Free PMC article. Updated.
-
Idiopathic (Genetic) Generalized Epilepsy.2024 Feb 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Feb 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31536218 Free Books & Documents.
-
Treatments for seizures in catamenial (menstrual-related) epilepsy.Cochrane Database Syst Rev. 2021 Sep 16;9(9):CD013225. doi: 10.1002/14651858.CD013225.pub3. Cochrane Database Syst Rev. 2021. PMID: 34528245 Free PMC article.
-
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.Cochrane Database Syst Rev. 2015 Aug 14;(8):CD001911. doi: 10.1002/14651858.CD001911.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2017 Feb 27;2:CD001911. doi: 10.1002/14651858.CD001911.pub3. PMID: 26275105 Updated.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources